Autopsy report · NCT04684251
ARTerial EMbolization for haemorrhoIdal Disease (ART.EM.I. Study)
Cause of deathFunding or business, also drug or device supply
“Funding no longer available.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Oxford University Hospitals NHS Trust
- Sponsor type
- University, hospital or other
- Conditions
- Haemorrhoidal Bleeding
- Interventions
- Coil embolisation of hemorrhoidal arteries.
- Participants
- 0
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides
“Funding discontinued” - A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer
“No more funding” - Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
“no longer had funding to continue” - Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females
“Funding unavailable.” - Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter
“Funding Stopped”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.